Plasma disappearance of exogenous erythropoietin in mice under different experimental conditions
- 34 Downloads
Erythropoietin (EPO) is a glycoprotein hormone produced primarily in the kidneys and to a lesser extent in the liver that regulates red cell production. Most of the studies conducted in experimental animals to assess the role of EPO in the regulation of erythropoiesis were performed in mouse models. However, little is known about the in vivo metabolism of the hormone in this species. The present study was thus undertaken to measure the plasma t 1/2 of radiolabeled recombinant human EPO (rh-EPO) in normal mice as well as in mice with altered erythrocyte production rates (EPR), plasma EPO (pEPO) titer, marrow responsiveness, red cell volume, or liver function. Adult CF-1 mice of both sexes were used throughout. For the EPO life-span studies, 30 mice in each experiment were intravenously injected with 600,000 cpm of 125I-rh-EPO and bled by cardiac puncture in groups of five every hour for 6 h. Trichloroacetic acid (TCA) was added to each plasma sample and the radioactivity in the precipitate measured in a γ-counter. EPO, pEPO, marrow responsiveness, or red cell volume were altered by either injections of rh-EPO, 5-fluorouracil, or phenylhydrazine, or by bleeding, or red cell transfusion. Liver function was altered by Cl4C administration. In the normal groups of mice, the estimated t 1/2 was 182.75 ± 14.4 (SEM) min. The estimated t 1/2 of the other experimental groups was not significantly different from normal. These results, therefore, strongly suggest that the clearance rate of EPO in mice is not subjected to physiologic regulation and that pEPO titer can be really taken as the reflection of the EPO production rate, at least in the experimental conditions reported here.
Key WordsErythropoietin clearance erythropoiesis
Unable to display preview. Download preview PDF.
- 1.Jelkmann, W. (1994). Clin. Invest. 72, S3-S10.Google Scholar
- 8.Bozzini, C. E. (1966). Acta Physiol. Latinoam. 16, 313–317.Google Scholar
- 9.Kinoshita, H., Ohishi, N., Kato, M., Tokura, S., and Okazaki, A. (1991). Arzneim-Forsch./Drug Res. 41, 1004–1007.Google Scholar
- 12.Widness, J. A., Kisthard, J. A., Veng-Pederson, P., Peters, C., Pereira, L. M., Schmidt, R. L., et al. (1994). Exp. Hematol. 22, 704 (abstract).Google Scholar